Propionate exerts neuroprotective and neuroregenerative effects in the peripheral nervous system.
Ontology highlight
ABSTRACT: In inflammatory neuropathies, oxidative stress results in neuronal and Schwann cell (SC) death promoting early neurodegeneration and clinical disability. Treatment with the short-chain fatty acid propionate showed a significant immunoregulatory and neuroprotective effect in multiple sclerosis patients. Similar effects have been described for patients with chronic inflammatory demyelinating polyneuropathy (CIDP). Therefore, Schwann cell's survival and dorsal root ganglia (DRG) outgrowth were evaluated in vitro after propionate treatment and application of H2O2 or S-nitroso-N-acetyl-D-L-penicillamine (SNAP) to evaluate neuroprotection. In addition, DRG resistance was evaluated by the application of oxidative stress by SNAP ex vivo after in vivo propionate treatment. Propionate treatment seco
SUBMITTER: Gruter T
PROVIDER: S-EPMC9942889 | biostudies-literature | 2023 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA